Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients

APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis

(2012) Worapot Treamtrakanpon et al.   ARTHRITIS RESEARCH & THERAPY

Inflammatory Cytokines in Systemic Lupus Erythematosus

(2011) Kim Ohl et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis

(2011) Z. Adhya et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices

(2010) M. Hegazy et al.   CLINICAL IMMUNOLOGY

Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes)

(2010) William Stohl   ARTHRITIS RESEARCH & THERAPY

Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus

(2009) Van Trung Chu et al.   ARTHRITIS AND RHEUMATISM

Interleukin-17 and systemic lupus erythematosus: current concepts

(2009) A. Nalbandian et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus

(2008) J Morel et al.   ANNALS OF THE RHEUMATIC DISEASES

APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response

(2008) Yanping Xiao et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms

(2008) Annie George-Chandy et al.   ARTHRITIS RESEARCH & THERAPY